2006
DOI: 10.1016/j.tmrv.2006.03.007
|View full text |Cite
|
Sign up to set email alerts
|

An Overview of Prion Biology and the Role of Blood Filtration in Reducing the Risk of Transfusion-Transmitted Variant Creutzfeldt-Jakob Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
8
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 107 publications
0
8
0
Order By: Relevance
“…Leukodepletion significantly reduced the risk of vCJD transmission in human following blood transfusion recipients as well [17,18]. However, a recent study by McCutcheon et al, (2011) revealed that leucoreduction did not prevent the BSE transmission to sheep following a single blood transfusion [11].…”
Section: Discussionmentioning
confidence: 99%
“…Leukodepletion significantly reduced the risk of vCJD transmission in human following blood transfusion recipients as well [17,18]. However, a recent study by McCutcheon et al, (2011) revealed that leucoreduction did not prevent the BSE transmission to sheep following a single blood transfusion [11].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, leukoreduction was proposed to reduce the risk of vCJD transmission through blood transfusion in humans. 13,23 However, leukoreduction could not prevent BSE transmission through …”
Section: Discussionmentioning
confidence: 99%
“…10 Due to a limited understanding of the properties of PrP Sc in the blood, several restrictions have been imposed on blood donation and the safety of blood-derived products, 11 which has increased the cost of these products. Reports of the transmission of both scrapie and bovine spongiform encephalopathy (BSE) by blood transfusion into sheep 12 and four cases of transmission of variant CreutzfeldtJakob disease (vCJD) through blood transfusions 13 heightened concerns about the safety of blood and blood products. 12 Another report suggested that the prevalence of subclinical vCJD infections could be as high as one in 4,000 people in certain UK cohorts.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, transfusion-related complications such as transfusion reactions, acute lung injury etc. could further complicate trauma patients receiving blood products (21)(22)(23)(24). Thus, Tranexamic acid would reduce transfusion needs and may decrease morbidity and mortality in traumatic patients in hemorrhagic shock (25)(26)(27).…”
Section: Introductionmentioning
confidence: 99%